BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2025.
World J Gastroenterol. Nov 7, 2025; 31(41): 111022
Published online Nov 7, 2025. doi: 10.3748/wjg.v31.i41.111022
Table 4 Risk factors for the development of post-procedure adverse events
VariableUnivariable analysis
Multivariable analysis
OR (95%CI)
P value
OR (95%CI)
P value
SBE (vs DBE)1.74 (1.00-3.10)0.0521.62 (0.82-3.23)0.164
Age > 65 years1.01 (0.58-1.77)0.984
Male sex1.05 (0.60-1.68)0.876
History of acute pancreatitis0.42 (0.07-1.44)0.245
Acute cholangitis on admission1.38 (0.79-2.39)0.256
PTBD prior ERCP2.16 (0.83-5.00)0.0871.79 (0.66-4.38)0.221
PTGBD prior ERCP1.86 (0.60-4.80)0.230
Resection
PD (vs BDR)0.68 (0.22-2.20)0.5100.36 (0.07-1.68)0.198
STG (vs BDR)2.17 (0.93-5.97)0.0960.04 (0.00-0.54)0.012
TG (vs BDR)1.70 (0.62-5.11)0.3140.04 (0.00-0.53)0.012
Reconstruction
B-II Braun (vs B-II)0.48 (0.21-1.02)0.0630.60 (0.24-1.40)0.245
R-Y (vs B-II)0.64 (0.34-1.19)0.1540.49 (0.19-1.18)0.126
Preserved gastric anatomy0.33 (0.16-0.62)0.0010.03 (0.00-0.34)0.003
Difficult cannulation2.42 (1.31-4.34)0.0042.21 (1.12-4.32)0.021
EPBD1.19 (0.68-2.07)0.530
EST1.74 (0.86-3.34)0.1060.89 (0.38-1.97)0.775
Biliary stent placement1.03 (0.56-1.83)0.921
Pancreatic stent placement0.87 (0.32-1.99)0.762


Write to the Help Desk